Navigation Links
Omeros Corporation Awarded $1.7 Million in Grants Under the Qualifying Therapeutic Discovery Project Program
Date:11/3/2010

SEATTLE, Nov. 3, 2010 /PRNewswire/ -- Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has been awarded non-taxable grants totaling approximately $1.7 million under the Qualifying Therapeutic Discovery Project (QTDP) included in the Patient Protection and Affordable Health Care Act of 2010.

To be eligible to receive a grant award under the QTDP program, projects must show reasonable potential to result in new therapies to treat areas of unmet medical need or prevent, detect, or treat chronic or acute disease and conditions; to reduce long-term health care costs in the United States; or to significantly advance the goal of curing cancer within 30 years. Grant applications were reviewed by both the Treasury Department and the Department of Health and Human Services.

About Omeros Corporation

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five ongoing clinical development programs, including four from its PharmacoSurgery(TM) platform, the most advanced of which is in a Phase 3 clinical program, and one from its Addiction program. Omeros may also have the near-term capability, through its GPCR program, to add wholly new drug targets to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of antibody and small-molecule preclinical programs targeting inflammation and cent
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Omeros Appoints David A. Mann to its Board of Directors
2. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
3. Omeros and BlueCrest Announce $20 Million Debt Facility
4. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
5. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
6. Omeros Appoints New Vice President of Clinical Development
7. Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery
8. Omeros Commences Initial Public Offering of Common Stock
9. Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
10. Omeros to Webcast Presentation at Deutsche Bank 35th Annual Health Care Conference
11. Omeros To Webcast Presentation at Ninth Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... (July 21, 2014) The yield so far is ... developed a low-energy, solution-based mineral substitution process to make ... use in electronics and alternative energy devices. , A ... of the July 21 issue of the journal ... research in the inorganic and nuclear chemistry fields. The ...
(Date:7/21/2014)... Sunset, LA (PRWEB) July 21, 2014 ... poor sleep quality are closely correlated with depression. ... Institutes of Health: "About three quarters of ... present in about 40% of young depressed adults ... in females. The symptoms cause huge distress, have ...
(Date:7/19/2014)... Albany, NewYork (PRWEB) July 20, 2014 ... 2020 , Summary , GlobalDatas new report, "United ... key market data on the United States Non-Vascular ... of US dollars, volume (in units) and average ... Biliary Stents (Plastic Biliary Stents and Metal Biliary ...
(Date:7/18/2014)... at the University of Illinois at Urbana-Champaign have ... nanoantennas (pBNAs) can be used like traditional photographic ... much smaller than the wavelength of light (for ... light). A standard optical microscope acts as a ... , "Unlike conventional photographic film, the effect (writing ...
Breaking Biology Technology:Oregon chemists eye improved thin films with metal substitution 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4'Nanocamera' takes pictures at distances smaller than light's own wavelength 2
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a leading ... venous reflux disease, today,announced the hiring of Guido Smeets, ... Officer., Dr. Smeets joins VNUS with over 17 ... served as the Head of Clinical Affairs for,Pelikan Technologies, ...
... OriGene Technologies, Inc.,announces its flagship products, TrueORF cDNA ... protein) vector, enabling easy transfection,monitoring and protein expression. ... frame) clones and 12,000 mouse ORF clones can ... the 2008 Nobel Prize in chemistry was awarded ...
... ThermoGenesis,Corp. (Nasdaq: KOOL ), a leading supplier ... announced today it will report,financial results for the fiscal ... 2008., Company,s Conference Call and Webcast, Management ... at,2:00 PM Pacific (5:00 PM Eastern) to review the ...
Cached Biology Technology:VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer 2OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector 2ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008 2
(Date:7/21/2014)... by neurobiologist Luke Remage-Healey at the University of ... the brains of young birds enhance their ability ... development. This period has a parallel to universal ... separate study, the UMass Amherst neuroscientist and colleagues ... the brain,s auditory cortex enhances the representation of ...
(Date:7/21/2014)... traditional apple orchards, effective management practices rely ... manage competitive vegetation under the trees, and ... factors are further complicated in organic management ... producers need to meet the stringent soil ... the National Organic Program. University of Arkansas ...
(Date:7/21/2014)... their body temperature, so their cells are stressed when ... temperatures, some biological processes in the cell are slowed ... delicate chemical balance out of whack. Yet, those cells ... from the University of Rochester and the European Molecular ... , "The production of proteins is a key ...
Breaking Biology News(10 mins):Studying estrogens made by the brain may offer new insights in learning and memory 2Studying estrogens made by the brain may offer new insights in learning and memory 3Organic apple orchards benefit from green compost applications 2When temperatures get cold, newly-discovered process helps fruit flies cope 2
... relatives of spiders that lived around 300 million years ... published today in the journal Biology Letters . ... detailed 3D computer models of two fossilised specimens of ... related to modern-day spiders. The study reveals some of ...
... A gene previously associated with physical traits is also ... a living model of Darwin,s natural selection theory, according ... three to 10 centimetres, stickleback fish originated in the ... the last ice age. Over the past 15,000 years, ...
... in the developing world is the key to ensuring ... Chair of the Global Form on Agricultural Research (GFAR), ... published last week. With nearly a billion people ... major concern, despite being a key goal of the ...
Cached Biology News:Scary ancient spiders revealed in 3-D models, thanks to new imaging technique 2Scary ancient spiders revealed in 3-D models, thanks to new imaging technique 3
... Osteocalcin EIA Kit is an in ... quantitative determination of human Gla-OC in ... supernatants, and other biological fluids. ... only. It is not for use ...
Antibodies were affinity purified using epitopes specific to Alpha4 immobilized on solid support....
in vitro Translation, Accessory Products...
Mouse Aminopeptidase P2/XPNPEP2 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Biology Products: